"Norgestrel" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A synthetic progestational agent with actions similar to those of PROGESTERONE. This racemic or (+-)-form has about half the potency of the levo form (LEVONORGESTREL). Norgestrel is used as a contraceptive, ovulation inhibitor, and for the control of menstrual disorders and endometriosis.
| Descriptor ID |
D009644
|
| MeSH Number(s) |
D04.210.500.668.651.693.762
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Norgestrel".
Below are MeSH descriptors whose meaning is more specific than "Norgestrel".
This graph shows the total number of publications written about "Norgestrel" by people in this website by year, and whether "Norgestrel" was a major or minor topic of these publications.
![]()
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Norgestrel" by people in Profiles.
-
Kaunitz AM, Burkman RT, Fisher AC, LaGuardia KD. Cycle control with a 21-day compared with a 24-day oral contraceptive pill: a randomized controlled trial. Obstet Gynecol. 2009 Dec; 114(6):1205-1212.
-
Burkman RT, Fisher AC, Wan GJ, Barnowski CE, LaGuardia KD. Association between efficacy and body weight or body mass index for two low-dose oral contraceptives. Contraception. 2009 Jun; 79(6):424-7.
-
Burkman RT, Fisher AC, LaGuardia KD. Effects of low-dose oral contraceptives on body weight: results of a randomized study of up to 13 cycles of use. J Reprod Med. 2007 Nov; 52(11):1030-4.
-
Burkman RT. Transdermal hormonal contraception: benefits and risks. Am J Obstet Gynecol. 2007 Aug; 197(2):134.e1-6.
-
Poindexter AN, Burkman R, Fisher AC, LaGuardia KD. Cycle control, tolerability, and satisfaction among women switching from 30-35 microg ethinyl estradiol-containing oral contraceptives to the triphasic norgestimate/25 microg ethinyl estradiol-containing oral contraceptive Ortho Tri-Cyclen LO. Int J Fertil Womens Med. 2003 Jul-Aug; 48(4):163-72.
-
Burkman RT. The transdermal contraceptive patch: a new approach to hormonal contraception. Int J Fertil Womens Med. 2002 Mar-Apr; 47(2):69-76.
-
Andolsek KM, Burkman RT, Kafrissen ME, Olson W, Osterman J. Metabolic effects and efficacy of a triphasic oral contraceptive (norgestimate/ethinyl estradiol). Int J Fertil Menopausal Stud. 1993; 38 Suppl 3:122-5.
-
Burkman RT, Kafrissen ME, Olson W, Osterman J. Lipid and carbohydrate effects of a new triphasic oral contraceptive containing norgestimate. Acta Obstet Gynecol Scand Suppl. 1992; 156:5-8.
-
Blaustein JD, Feder HH. Cytoplasmic progestin-receptors in guinea pig brain: characteristics and relationship to the induction of sexual behavior. Brain Res. 1979 Jun 29; 169(3):481-97.